Aviv Madar

3.5k total citations · 1 hit paper
16 papers, 1.3k citations indexed

About

Aviv Madar is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Aviv Madar has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Aviv Madar's work include Gene Regulatory Network Analysis (5 papers), Bioinformatics and Genomic Networks (5 papers) and CAR-T cell therapy research (3 papers). Aviv Madar is often cited by papers focused on Gene Regulatory Network Analysis (5 papers), Bioinformatics and Genomic Networks (5 papers) and CAR-T cell therapy research (3 papers). Aviv Madar collaborates with scholars based in United States, Switzerland and United Kingdom. Aviv Madar's co-authors include Richard Bonneau, Alex Greenfield, Harry Ostrer, Sònia Guedan, Carl H. June, Avery D. Posey, Eric Vanden‐Eijnden, Matthew J. Frigault, Carmine Carpenito and Ji‐Hyun Lee and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Aviv Madar

16 papers receiving 1.2k citations

Hit Papers

TET2-Driven Clonal Hematopoiesis and Response to Canakinumab 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aviv Madar United States 12 637 427 261 217 158 16 1.3k
Travis Law United States 6 994 1.6× 301 0.7× 243 0.9× 111 0.5× 112 0.7× 8 1.3k
Hiro Shimada United States 8 689 1.1× 542 1.3× 306 1.2× 118 0.5× 55 0.3× 14 1.7k
Jishuai Zhang China 23 889 1.4× 392 0.9× 184 0.7× 145 0.7× 76 0.5× 50 1.4k
Matthew MacKay United States 12 1.2k 1.9× 378 0.9× 143 0.5× 148 0.7× 112 0.7× 20 1.7k
Lukas P. Frenzel Germany 19 664 1.0× 354 0.8× 304 1.2× 50 0.2× 40 0.3× 34 1.3k
Isabelle Robert France 19 1.1k 1.8× 710 1.7× 445 1.7× 72 0.3× 36 0.2× 36 1.7k
Daniel C. Kirouac United States 16 684 1.1× 270 0.6× 166 0.6× 51 0.2× 269 1.7× 28 1.2k
Andrea M. Griesinger United States 17 759 1.2× 300 0.7× 224 0.9× 53 0.2× 52 0.3× 37 1.3k
Ru‐Fang Yeh United States 20 1.9k 3.0× 379 0.9× 148 0.6× 310 1.4× 117 0.7× 26 2.7k
Silvana Debernardi United Kingdom 21 1.4k 2.2× 244 0.6× 91 0.3× 256 1.2× 74 0.5× 39 2.1k

Countries citing papers authored by Aviv Madar

Since Specialization
Citations

This map shows the geographic impact of Aviv Madar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aviv Madar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aviv Madar more than expected).

Fields of papers citing papers by Aviv Madar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aviv Madar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aviv Madar. The network helps show where Aviv Madar may publish in the future.

Co-authorship network of co-authors of Aviv Madar

This figure shows the co-authorship network connecting the top 25 collaborators of Aviv Madar. A scholar is included among the top collaborators of Aviv Madar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aviv Madar. Aviv Madar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Svensson, E. C., Aviv Madar, Catarina D. Campbell, et al.. (2022). TET2-Driven Clonal Hematopoiesis and Response to Canakinumab. JAMA Cardiology. 7(5). 521–521. 218 indexed citations breakdown →
2.
Delgado, Ana C., Angel R. Maldonado‐Soto, Violeta Silva-Vargas, et al.. (2021). Release of stem cells from quiescence reveals gliogenic domains in the adult mouse brain. Science. 372(6547). 1205–1209. 51 indexed citations
3.
Scotti, Celeste, Joseph Gimbel, Didier Laurent, et al.. (2021). First-in-human trial results of LNA043, a novel cartilage regenerative treatment for osteoarthritis. Osteoarthritis and Cartilage. 29. S214–S214. 1 indexed citations
4.
Guedan, Sònia, Aviv Madar, Victoria Casado‐Medrano, et al.. (2020). Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability. Journal of Clinical Investigation. 130(6). 3087–3097. 126 indexed citations
5.
Miraldi, Emily R., Maria Pokrovskii, Aaron Watters, et al.. (2019). Leveraging chromatin accessibility for transcriptional regulatory network inference in T Helper 17 Cells. Genome Research. 29(3). 449–463. 67 indexed citations
6.
Svensson, E. C., Aviv Madar, Catarina D. Campbell, et al.. (2018). Abstract 15111: TET2-Driven Clonal Hematopoiesis Predicts Enhanced Response to Canakinumab in the CANTOS Trial: An Exploratory Analysis. Circulation. 32 indexed citations
7.
Gonsalves, Foster C., Xiaoqian Zhang, Penelope Hayward, et al.. (2015). Inhibition of β-catenin–TCF1 interaction delays differentiation of mouse embryonic stem cells. The Journal of Cell Biology. 211(1). 39–51. 30 indexed citations
8.
Chang, Diana, Feng Gao, Yedael Y. Waldman, et al.. (2014). Accounting for eXentricities: Analysis of the X Chromosome in GWAS Reveals X-Linked Genes Implicated in Autoimmune Diseases. PLoS ONE. 9(12). e113684–e113684. 75 indexed citations
9.
Guedan, Sònia, Xi Chen, Aviv Madar, et al.. (2014). ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells. Blood. 124(7). 1070–1080. 275 indexed citations
10.
Yu, Bowen, Harish Doraiswamy, Xi Chen, et al.. (2014). Genotet: An Interactive Web-based Visual Exploration Framework to Support Validation of Gene Regulatory Networks. IEEE Transactions on Visualization and Computer Graphics. 20(12). 1903–1912. 9 indexed citations
11.
Lee, Eugine, Aviv Madar, Gregory David, et al.. (2013). Inhibition of androgen receptor and β-catenin activity in prostate cancer. Proceedings of the National Academy of Sciences. 110(39). 15710–15715. 87 indexed citations
12.
Guedan, Sònia, Carmine Carpenito, Xi Chen, et al.. (2013). Redirection of TH17 cells with a chimeric antigen receptor containing the ICOS costimulatory domain enhances function, antitumor activity and persistence of TH17 cells (P4350). The Journal of Immunology. 190(Supplement_1). 177.8–177.8. 1 indexed citations
13.
Madar, Aviv, Alex Greenfield, Eric Vanden‐Eijnden, & Richard Bonneau. (2010). DREAM3: Network Inference Using Dynamic Context Likelihood of Relatedness and the Inferelator. PLoS ONE. 5(3). e9803–e9803. 69 indexed citations
14.
Greenfield, Alex, Aviv Madar, Harry Ostrer, & Richard Bonneau. (2010). DREAM4: Combining Genetic and Dynamic Information to Identify Biological Networks and Dynamical Models. PLoS ONE. 5(10). e13397–e13397. 173 indexed citations
15.
Madar, Aviv & Richard Bonneau. (2009). Learning Global Models of Transcriptional Regulatory Networks from Data. Methods in molecular biology. 541. 181–210. 11 indexed citations
16.
Madar, Aviv, Andy Greenfield, Harry Ostrer, Eric Vanden‐Eijnden, & Richard Bonneau. (2009). The inferelator 2.0: A scalable framework for reconstruction of dynamic regulatory network models. PubMed. 2009. 5448–5451. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026